ArticleCancer2024

Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.

Oren Pasvolsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.